HOLLY BLANKENSHIP: Open Payments
NPI 1720793888 · RICHLANDS, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$631 in 35 payments from 13 companies in 2025. Trend: 2023 $250 · 2024 $626 · 2025 $631
Food & beverage: $631
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 8 | $161 |
| Organogenesis Inc. | 9 | $157 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $86 |
| Xeris Pharmaceuticals, Inc. | 3 | $50 |
| Advanced Oxygen Therapy Inc. | 2 | $31 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $28 |
| Esperion Therapeutics, Inc. | 1 | $20 |
| Insulet Corporation | 1 | $19 |
| Kerecis Limited | 1 | $17 |
| Smith+Nephew, Inc. | 1 | $16 |
Products named: JARDIANCE, Kerendia, CYGNUS MATRIX, CYGNUS DUAL, GVOKE HYPOPEN, MOUNJARO, Topical Oxygen Chamber for extremities, VIA MATRIX.
Industry payments across VA — which companies pay providers there.
